Silo Pharma, Inc.

As of June 6, 2025, the market trend is mildly bearish due to bearish weekly MACD and KST indicators, despite some bullish signals from the monthly MACD and weekly RSI, indicating a cautious outlook.

Silo Pharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $1 million as of March 2025, with a market cap of $4.35 million. Key financial metrics indicate it is loss-making with a negative return on equity of -115.21%.

As of Jun 18, Silo Pharma, Inc. has a market capitalization of 4.35 million, with net sales of 0.08 million and a net profit of -4.62 million over the last four quarters. The company's shareholder's funds are 5.03 million, and total assets are 7.41 million.